Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2013

Open Access 01-12-2013 | Research article

The long-term coronary heart disease risk of previously obese patients with type 2 diabetes mellitus

Authors: Ritsuko Yamamoto-Honda, Hideki Ehara, Hiroji Kitazato, Yoshihiko Takahashi, Shoji Kawazu, Yasuo Akanuma, Mitsuhiko Noda

Published in: BMC Endocrine Disorders | Issue 1/2013

Login to get access

Abstract

Background

Obesity is associated with insulin resistance, development of diabetes, and coronary heart disease. There is limited information on the contribution of previous obesity on the risk of coronary heart disease. We aimed to examine the effect of previous history of obesity on the occurrence of coronary heart disease in patients with diabetes.

Methods

We carried out a retrospective chart analysis of 315 type 2 diabetic patients without obesity and without atherosclerotic cardiovascular events at their initial hospital visit (men/women 236/79; mean ± standard deviation; age 53.1 ± 6.6 years; maximal body mass index before enrollment (MAXBMI) 26.6 ± 3.4 kg/m2; decrease of the BMI at enrollment from MAXBMI (deltaBMI) 4.23 ± 2.62 kg/m2) to investigate the association of previous obesity (MAXBMI larger than 30 kg/m2) with the long-term incidence of cardiovascular events. Of 315 patients, forty-eight were previously obese.

Results

After median follow-up of 13.9 years, 48 patients developed coronary heart disease. The Kaplan-Meier analysis exhibited that coronary heart disease occurred more frequently in previously obese patients than in subjects in the reference category (22 kg/m2 < or = MAXBMI < 25 kg/m2) and that the effect lasted proportionally over follow-up periods. Multivariate Cox regression models showed that hazard ratios and corresponding 95% confidence intervals of coronary heart disease for patients with previous obesity compared with subjects in the reference category were 2.52 and 1.15 to 5.50 (p value = 0.020) after adjustment for age, sex, smoking status, systolic blood pressure, total cholesterol and HDL cholesterol. In this cohort, deltaBMI strongly correlated with MAXBMI and also behaved as a risk factor. The hazard ratios and 95% confidence intervals by the increment of one standard deviation of deltaBMI after adjustment for age, sex, smoking status, systolic blood pressure, total cholesterol and HDL cholesterol were 1.38 and 1.08 to 1.79 (p value = 0.013).

Conclusions

Previous obesity and/or large body weight loss before admission might act as an increased risk for coronary heart disease.
Appendix
Available only for authorised users
Literature
1.
Nakamura Y, Yamamoto T, Okumura T, Kadowaki T, Hayakawa T, Kita Y, Saitoh S, Okayama A, Ueshima H, The NIPPON DATA 80 Research Group: Combined cardiovascular risk factors and outcome: NIPPON DATA80, 1980–1994. Circ J. 2006, 70: 960-964. 10.1253/circj.70.960.CrossRefPubMed
2.
Nanri A, Mizoue T, Takahashi Y, Matsushita Y, Noda M, Inoue M, Tsugane S, Japan Public Health Center-based Prospective Study Group: Association of weight change in different periods of adulthood with risk of type 2 diabetes in Japanese men and women: the Japan public health center-based prospective study. J Epidemiol Community Health. 2011, 65: 1104-1110. 10.1136/jech.2009.097964.CrossRefPubMed
3.
Wannamethee SG, Shaper AG: Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care. 1999, 22: 1266-1272. 10.2337/diacare.22.8.1266.CrossRefPubMed
4.
Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97: 1837-1847. 10.1161/01.CIR.97.18.1837.CrossRefPubMed
5.
Tanabe N, Iso H, Okada K, Nakamura Y, Harada A, Ohashi Y, Ando T, Ueshima H, Japan Arteriosclerosis Longitudinal Study Group: Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular events – the JALS-ECC. Circ J. 2010, 74: 1346-1356. 10.1253/circj.CJ-09-0861.CrossRefPubMed
6.
Matsushita Y, Takahashi Y, Mizoue T, Inoue M, Noda M, Tsugane S, JPHC study Group: Overweight and obesity trends among Japanese adults: a 10-year follow-up of the JPHC Study. Int J Obes (Lond). 2008, 32: 1861-1867. 10.1038/ijo.2008.188.CrossRef
7.
Funatogawa I, Funatogawa T, Nakao M, Karita K, Yano E: Changes in body mass index by birth cohort in Japanese adults: results from the National Nutrition Survey of Japan 1956–2005. Int J Epidemiol. 2009, 38: 83-92. 10.1093/ije/dyn182.CrossRefPubMed
8.
Cui R, Iso H, Toyoshima H, Date C, Yamamoto A, Kikuchi S, Kondo T, Watanabe Y, Koizumi A, Wada Y, Inaba Y, Tamakoshi A, JACC Study Group: Mass index and risk of stroke and myocardial infarction in a relatively lean population: meta-analysis of 16 Japanese cohorts using individual data. Circ Cardiovasc Qual Outcomes. 2010, 3: 498-505. 10.1161/CIRCOUTCOMES.109.908517.CrossRef
9.
Kyulo NL, Knutsen SF, Traser GE, Singh PN: Effect of weight loss in adults on estimation of risk due to adiposity in a cohort study. Obesity (Silver Spring). 2012, 20: 206-213. 10.1038/oby.2011.281.CrossRef
10.
Carnethon MR, De Chavez PJ, Mujahid MS, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, Golden SH, Liu K, Mukamal KJ, Campbell-Jenkins B, Dyer AR: Association of weight status with mortality in adults with incident diabetes. JAMA. 2012, 308: 581-590. 10.1001/jama.2012.9282.PubMedPubMedCentral
11.
Ogawa K, Ueda K, Sasaki H, Yamasaki H, Okamoto K, Wakasaki H, Matsumoto E, Furuta H, Hanabusa T, Nishi M, Nanjo K: History of obesity as a risk factor for both carotid atherosclerosis and microangiopathy. Diabetes Res Clin Prac. 2004, 66: S165-S169.CrossRef
12.
Tanaka S, Honda M, Wu B, Kazumi T: Clinical features of normal weight Japanese patients with type 2 diabetes who had formerly been obese. J Atheroscler Thromb. 2011, 18: 115-121. 10.5551/jat.5926.CrossRefPubMed
13.
Murakami K, Shimizu M, Yamada N, Ishibashi S, Shimano H, Yazaki Y, Akanuma Y: Apolipoprotein E polymorphism is associated with plasma cholesterol response in a 7-day hospitalization study for metabolic and dietary control in NIDDM. Diabetes Care. 1993, 16: 564-569. 10.2337/diacare.16.4.564.CrossRefPubMed
14.
Ehara H, Yamamoto-Honda R, Kitazato H, Takahashi Y, Kawazu S, Akanuma Y, Noda M: ApoE isoforms, treatment of diabetes and the risk of coronary heart disease. World J Diabetes. 2012, 3: 54-59. 10.4239/wjd.v3.i3.54.CrossRefPubMedPubMedCentral
15.
Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Hiroshi I, Tominaga M, Oikawa S, Noda M, Kawamura T, Sanke T, Namba M, Hashiramoto M, Sasahara T, Nishio Y, Kuwa K, Ueki K, Takei I, Umemoto M, Murakami M, Yamakado M, Yatomi Y, Ohashi H, Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society: “International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values”. Diabetol Int. 2012, 3: 8-10. 10.1007/s13340-012-0069-8. DOI: 10.1007/ s13340-012-0069-8CrossRef
16.
Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.PubMed
17.
Hubert HB, Feinleib M, McNamara PM, Castelli WP: Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation. 1983, 67: 968-977. 10.1161/01.CIR.67.5.968.CrossRefPubMed
18.
R Development Core Team. R: A language and environment for statistical computing. 2007, Vienna, Austria: R Foundation for Statistical Computing, ISBN 3-900051-07-0
19.
Murai A, Miyahara T, Fujimoto N, Kameyama M: Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis. 1986, 59: 199-204. 10.1016/0021-9150(86)90048-1.CrossRefPubMed
20.
Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, Adachi Y: Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endcrinol Metab. 2003, 88: 4673-4676. 10.1210/jc.2003-030202.CrossRef
21.
Noto H: Impaired functionality of HDL in diabetes. Diabetol Int. 2012, 3: 5-7. 10.1007/s13340-011-0059-2.CrossRef
22.
Onat A, Hergenç G: Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk. Metabolism. 2011, 60: 499-512. 10.1016/j.metabol.2010.04.018.CrossRefPubMed
23.
Onat A, Can G, Ciçek G, Ayhan E, Doğan Y, Kaya H: Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults. Acta Diabetol. 2011, Epub ahead of print
24.
Wang Y, Snei M, Jonker JT, Lamb HJ, Meinders AE, Pijl H, Romijn JA, Smit JW, Janet IM, Rensen PC: Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases plasma CETP and increases apolipoprotein A1 levels without improving the cholesterol efflux properties of HDL. Diabetes Care. 2011, 34: 2576-2580. 10.2337/dc11-0685.CrossRefPubMedPubMedCentral
25.
Formoso G, Taraborrelli M, Guagnano MT, D’Adamo M, Pietro ND, Tartaro A, Consoli A: Resonance imaging determined visceral Fat reduction associates with enhanced IL-10 plasma levels in calorie restricted obese subjects. PLoS One. 2012, 7: e52774-10.1371/journal.pone.0052774.CrossRefPubMedPubMedCentral
26.
Ochi M, Kohara K, Tabara Y, Uetani E, Ochi N, Igase M, Miki T: Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis. 2010, 212: 327-332. 10.1016/j.atherosclerosis.2010.05.026.CrossRefPubMed
27.
Lee Y, Shin H, Kim JT, Cho SI, Kang SM, Choi SH, Kim KW, Park KS, Jang HC, Lim S: Comparison of regional body composition and its relation with cardiometabolic risk between BMI-matched young and old subjects. Atherosclerosis. 2012, 224: 258-265. 10.1016/j.atherosclerosis.2012.07.013.CrossRefPubMed
28.
Park SW, Goodpaster BH, Lee JS, Kuller LH, Boudreu R, de Rekeneire N, Harria TB, Krichevsky S, Tylavsky FA, Nevitt M, Cho YW, Newmann AB: Health, aging, and body composition study. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care. 2009, 32: 1933-1937.
29.
Srikanthan P, Hevener AL, Karlamangla AS: Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One. 2010, 5: e10805-10.1371/journal.pone.0010805.CrossRefPubMedPubMedCentral
30.
Ruderman NB, Schneider SH, Berchtold P: The “metabolically-obese”, normal-weight individual. Am J Clin Nutr. 1981, 34: 1617-1621.PubMed
31.
Stevens J, Erber E, Truesdale KP, Wang CH, Cai J: Long- and short-term weight change and incident coronary heart disease and ischemic stroke: the atherosclerosis risk in communities study. Am J Epidemiol. 2013, 178: 239-248. 10.1093/aje/kws461.CrossRefPubMedPubMedCentral
32.
Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM, Diabetes Prevention Program Research Group: 10-Year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet. 2009, 374: 1677-1686. 10.1016/S0140-6736(09)61457-4.CrossRefPubMed
33.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002, 346: 393-403.CrossRefPubMed
34.
Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ: Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005, 293: 43-53. 10.1001/jama.293.1.43.CrossRefPubMed
35.
Siebenhofer A, Jeitler K, Berghold A, Waltering A, Hemkens LG, Semlitsch T, Pachler C, Strametz R, Horvath K: Long-term effects of weight-reducing diets in hypertensive patients. Cochrane Database Syst Rev. 2011, 7: CD008274
Metadata
Title
The long-term coronary heart disease risk of previously obese patients with type 2 diabetes mellitus
Authors
Ritsuko Yamamoto-Honda
Hideki Ehara
Hiroji Kitazato
Yoshihiko Takahashi
Shoji Kawazu
Yasuo Akanuma
Mitsuhiko Noda
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2013
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-13-38

Other articles of this Issue 1/2013

BMC Endocrine Disorders 1/2013 Go to the issue

Research article

Insulin resistance as estimated by the homeostatic method at diagnosis of gestational diabetes: estimation of disease severity and therapeutic needs in a population-based study

Research article

Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study

Research article

Beneficial association of serum ghrelin and peptide YY with bone mineral density in the Newfoundland population

Research article

Reference intervals for serum osteocalcin concentrations in adult men and women from the study of health in Pomerania

Research article

Combining glycosylated hemoglobin A1c and fasting plasma glucose for diagnosis of type 2 diabetes in Chinese adults

Research article

Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits